Mundipharma has acquired all assets and rights related to rezafungin globally from Cidara Therapeutics.
This provides Mundipharma with global ownership of rezafungin including ongoing development...
Ipsen and Skyhawk Therapeutics have signed an exclusive worldwide collaboration to discover and develop novel small molecules that modulate RNA for rare neurological diseases.
The...
Ochre Bio has formed a partnership with Boehringer Ingelheim focused on the discovery and development of novel, first-in-class regenerative treatments for chronic liver diseases (CLDs),...